Article info

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study

Authors

  1. Correspondence to Professor Christian Prünte, Department of Ophthalmology, Augenklinik Kantonsspital Baselland, Rheinstrasse 26, Liestal CH-4410, Switzerland; christian.pruente{at}ksbl.ch, christian{at}pruente.ch
View Full Text

Citation

Prünte C, Fajnkuchen F, Mahmood S, et al
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study

Publication history

  • Received June 1, 2015
  • Revised September 8, 2015
  • Accepted September 9, 2015
  • First published October 9, 2015.
Online issue publication 
May 20, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.